Anuncio
Anuncio

REGN

REGN logo

Regeneron Pharmaceuticals Inc

611.34
USD
Patrocinado
-24.11
-3.79%
08 jun, 16:00 UTC -4
Cerrado
exchange

Post-mercado

612.00

+0.66
+0.11%

Panorámica financiera de Regeneron Pharmaceuticals Inc

Cap. de Mercado
64.16B
Beta
0.40
Beneficios Por Acción (BPA)
41.56
Ratio Precio/Valor (P/V) Contable
2.60
Margen de explotación
27.63%
Ratio de Endeudamiento total (D/C)
8.66%
Ratio PER
21.28
Rentabilidad sobre recursos propios (ROE)
13.04%
Ratio de liquidez
4.13%
Flujo de caja libre
4.08B
Perfil de REGN

Gráfico de Beneficios

Beneficios de REGN

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$949.28
+9.87%
Nvidia Corp logo
Nvidia Corp$208.64
+1.73%
Marvell Technology, Inc. Common Stock logo
Marvell Technology, Inc. Common Stock$288.85
+9.63%
Apple Inc. logo
Apple Inc.$301.54
-1.89%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$408.95
+4.59%
Intel Corp logo
Intel Corp$110.27
+11.19%
Broadcom Inc. Common Stock logo
Broadcom Inc. Common Stock$396.60
+2.82%
Anuncio